Entry |
|
Name |
Namodenoson (USAN/INN) |
Formula |
C18H18ClIN6O4
|
Exact mass |
544.0123
|
Mol weight |
544.73
|
Structure |

|
Simcomp |
|
Efficacy |
Anti-inflammatory, Antineoplastic |
Comment |
Treatment of hepatocellular carcinoma and nonalcoholic steatohepatitis
|
Target |
|
Pathway |
hsa04080 | Neuroactive ligand-receptor interaction |
|
Brite |
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adenosine
ADORA3
D11128 Namodenoson (USAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 30
1 N4y N 16.8653 -15.7407
2 C8y C 17.8491 -16.5840
3 C1y C 15.6005 -16.1624
4 C8x C 17.4978 -14.4056
5 C8y C 19.1842 -15.8110
6 N5x N 17.8491 -17.9894
7 O2x O 14.4059 -15.3191
8 C1y C 15.1086 -17.4272
9 N5x N 18.9032 -14.5462
10 C8y C 20.3788 -16.4434
11 C8y C 19.1140 -18.6921
12 C1y C 13.3518 -16.0921
13 C1y C 13.7735 -17.4272
14 O1a O 15.5302 -18.7624
15 N5x N 20.3788 -17.9191
16 N1b N 21.5734 -15.7407
17 O1a O 13.2816 -18.7624
18 C5a C 12.0167 -15.6705
19 N1b N 10.7518 -16.3732
20 O5a O 11.9464 -14.2651
21 C1a C 9.5573 -15.6002
22 C1b C 22.7680 -16.3732
23 C8y C 23.9626 -15.6705
24 C8x C 25.2275 -16.3732
25 C8y C 26.4220 -15.6705
26 C8x C 26.4220 -14.2651
27 C8x C 25.2275 -13.6326
28 C8x C 23.9626 -14.2651
29 X I 27.6166 -16.3732
30 X Cl 19.1429 -20.0896
BOND 33
1 1 2 1
2 3 1 1 #Up
3 1 4 1
4 2 5 2
5 2 6 1
6 3 7 1
7 3 8 1
8 4 9 2
9 5 10 1
10 6 11 2
11 7 12 1
12 8 13 1
13 8 14 1 #Down
14 10 15 2
15 10 16 1
16 13 17 1 #Down
17 5 9 1
18 11 15 1
19 12 13 1
20 12 18 1 #Up
21 18 19 1
22 18 20 2
23 19 21 1
24 16 22 1
25 22 23 1
26 23 24 2
27 24 25 1
28 25 26 2
29 26 27 1
30 27 28 2
31 23 28 1
32 25 29 1
33 11 30 1
|